Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.
Wall Street Beat
Will another Durata failure report drag St. Jude down?
Wall Street didn’t move much on news of another insulation-related failure in St. Jude Medical’s (NYSE:STJ) next-generation Durata defibrillator leads this week.
Venture capital: Third Rock Ventures’ new $516M fund, investment manifesto and recipe for success
Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.
The Boston-based VC group recently closed its 3rd fund, a $516 million tranche that will go towards launching some 15 to16 new life science companies in the coming months. In the past 6 years Third Rock Ventures has raised more than $1.3 billion and launched some 31 companies across the life sciences spectrum.
Medtech M&A report: Quality beats quantity in 2012, with more activity ahead
The medical device sector posted some strong merger & acquisition figures in 2012, and the year ahead is looking bright as well, according to a report from analysts at PricewaterhouseCoopers.
Angiotech hands $363M in interventional assets back to Argon Medical
Angiotech Pharmaceuticals plans to retire all of its outstanding debt obligations with part of the $362.5 million it stands to gain through the sale of its interventional products business back to Argon Medical Devices.
The battle over robotic surgery keeps heating up
EndoStim takes funding round to $11M | Wall Street Beat
EndoStim added another tranche to its $16.5 million equity round, according to a regulatory filing, saying it’s added some $11.2 million to its coffers as it develops a pacemaker-like implant to treat gastro-esophageal reflux disease.
Robotic surgery: Mass. advisory sends Intuitive Surgical, Mako, Hansen shares down
Shares of the leading robotic surgery device makers all fell today, after a Massachusetts medical board issued an advisory to surgeons warning of possible risks with the cutting-edge technology.
Cardiovascular Systems prices $33M offering | Wall Street Beat
Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.
Report: Medtronic may offer $3B in bonds in 2013 | MassDevice.com On Call
Analysts defend Intuitive Surgical as docs defend robot-assisted surgery
Updated March 18, 2013, at 2:15 p.m. with a correction.